Clinical Trial Update: Split-face Tolerability Comparison Between MetroGel® 1% vs Finacea® 15% in Subjects With Healthy Skin [Phase 4]

View source ↗

Summary

Phase 4 trial comparing tolerability of MetroGel 1% vs Finacea 15% on split-face in healthy skin; completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Skin Manifestations

Drugs mentioned

• Finacea 15% (azelaic acid)
• MetroGel 1% (metronidazole)

Snippet

Sponsor: Galderma R&D | Conditions: Skin Manifestations | Phase 4 | Status: COMPLETED | Results posted: 2011-07-26